Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: Reduction in size of the fibroids and women's views of the success of the treatment

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 2, 2002, Pages 129-135

  Watson, G M T ^a   Walker, W J ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; ARTIFICIAL EMBOLISM; LEIOMYOMA; METHODOLOGY; UTERUS CANCER; VASCULARIZATION;

ADULT; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0036484110     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2002.01006.x     Document Type: Article

References (18)

1. Wallach E.E., Vu K.K. Myomata uteria and infertility. Obstet Gynecol Clin North Am. 11:1995;791-799.
2. Buttram V.C., Reiter R.C. Uterine Leiomyomata: etiology, symptomatology, and management. Fertil Steril. 36:1981;433-455.
3. Wilcox L.S., Koonin L.M., Pokras Ret al. Hysterectomy in the United States 1988-1990. Obstet Gynecol. 83:1994;549-555.
4. Hill D.J. Complications of hysterectomy. Balliere's Clin Obstet Gynecol. 11:1997;181-195.
5. Wingo P.A., Huezo C.M., Rubin GLet al. The majority risk associated with hysterectomy. Am J Obstet Gynecol. 152:1986;803-808.
6. Takamizawa S., Minakami H., Usui Ret al. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest. 48:1999;193-196.
7. Hutchins J.R., Worthington-Kirsch R.L., Berkowitz R.P. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparo. 6:1999;279-284.
8. Walker W., Green A., Sutton C. Bilateral uterine artery embolisation for myomata: results, complications and failures. Min Invas Ther Allied Technol. 8:1999;449-454.
9. Goodwin S.C., Walker W.J. Uterine artery embolisation for the treatment of uterine fibroids. Obstet Gynecol. 10:1998;315-320.
10. Walker W.J. Bilateral uterine artery embolisation for fibroids. Sheth C., Sutton C. Menorrhagia. 1999;185-193 Isis Medical Media, Oxford.
11. Goodwin S.C., McLucas B., Lee Met al. Uterine artery embolization for the treatment of uterine leiomyomata. Midterm results. J Vasc Intervent Radiol. 10:1999;1159-1165.
12. Jha R.C., Ascher S.M., Imaoka I., Spies J.B. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 217:2000;228-235.
13. Burn P.R., McCall J.M., Chinn R.J., Vashisht A., Smith J.R., Healy J.C. Radiology. 214:2000;729-734.
14. McLucas B., Adler L., Perella R. Predictive factors for success in uterine fibroid embolisation. Min Invas Ther Allied Technol. 8:1999;429-432.
15. Ooto H., Nanbu Y., Nonogaki Het al. Treatment with LH-RH analogue, Buserelin for uterine leiomyoma: assessment with MR imaging. Endometriosis Kenkyukai Kaishi. 10:1989;245-249.
16. Oguchi O., Mori A., Kobayashi Y., Horiuchi A., Nikaido T., Fujii S. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Comput Assist Tomogr. 18:1994;925-928.
17. Dellacha A., Di Marco A., Fooglia G., Fulcheri E. Lipoleiomyoma of the uterus. Pathological. 89:1997;737-741 [Italian].
18. Kawakami S., Togashi K., Konishi Iet al. Red degeneration of uterine leiomyoma; MRI appearances. J Comput Assist Tomogr. 18:1994;925-928.